by Elena Iemma | Jun 27, 2023 | Uncategorized
Developing biologics? EpiVax’s High Throughput Immunogenicity Assessment provides a comprehensive assessment of potential clinical immunogenicity for large sets of biologic candidates. This approach allows preclinical researchers to compare the immunogenic...
by Elena Iemma | May 31, 2023 | Featured, Thinking Out Loud -Blog
HI + AI + SMC = EpiVax 2.0 Oh my, oh my! Artificial intelligence (AI) developers and media pundits are predicting ‘an extinction event’, if AI runs rampant. While their warnings should be heeded, AI is already ‘out of the box’. And since...
by Elena Iemma | May 17, 2023 | Featured, News
PROVIDENCE, RI, May 17, 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is celebrating its 25th birthday by renewing the company’s commitment to improving human health everywhere while highlighting the development of groundbreaking tools by the company. In addition,...
by Elena Iemma | May 16, 2023 | Featured, News
EpiVax is celebrating 25 years of innovative immunoinformatics tool development. The company’s mission is to improve the safety and efficacy of vaccines and protein therapeutics, while working to improve human health everywhere. 1998 EpiVax Founded by Dr. Annie De...
by Elena Iemma | May 1, 2023 | Featured, Thinking Out Loud -Blog
25 years of Fearless Science and… EpiVax 2.0! In case you hadn’t heard (heh), EpiVax turns 25 this year. Really. We truly never imagined this future, but we’ve had a ton of fun working with amazing scientists / friends / colleagues and...
